Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
December 17, 2024 08:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
December 13, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
December 12, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Third Quarter 2024 Financial Results
November 11, 2024 16:02 ET
|
Assertio Holdings, Inc.
Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 ...
Assertio Provides Response to Letter from Short-seller
November 11, 2024 07:30 ET
|
Assertio Holdings, Inc.
Claims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich Himself at Assertio’s Expense Company Considering...
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
October 30, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
October 11, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 04, 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
September 03, 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Second Quarter 2024 Financial Results
August 07, 2024 16:01 ET
|
Assertio Holdings, Inc.
Assertio Reports Second Quarter 2024 Financial Results